semaglutide access Shares in Danish drugmaker Novo Nordisk soar on weight-loss drugs Ozempic and Wegovy Global rules could cut costs

Among all medications used for weight loss, the most commonly reported side effects are nausea and constipation, but irreversible gallbladder and pancreatic disease is also reported

I do worry a little bit that health care consumers are so accustomed to paying big numbers and so accustomed to not looking at prices that maybe they wont be quite as quick to adjust to this new system

Swiss pharmaceutical firm Roche is targeting becoming a top three obesity player globally, posing a potential rival to heavyweights Novo Nordisk and Eli Lilly as it advances one of its experimental weight-loss drugs to a late-stage trial

Wegovy pens look different from Zepbound pens